Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
199.50
-1.01 (-0.50%)
Official Closing Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
70
71
Next >
3 Things You Need to Know if You Buy AbbVie Stock Today
September 09, 2024
This dynamic big pharma is undergoing a few key changes.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
September 08, 2024
These stocks pay great dividends and could be long-term winners.
Via
The Motley Fool
Earn $1,000 Per Month in Dividends From These 4 Stocks
September 07, 2024
A mix of various types of dividend investments.
Via
The Motley Fool
Peering Into AbbVie's Recent Short Interest
September 06, 2024
Via
Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI advancements in drug development.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
September 05, 2024
Via
Benzinga
AbbVie Options Trading: A Deep Dive into Market Sentiment
August 29, 2024
Via
Benzinga
AbbVie Unusual Options Activity For August 26
August 26, 2024
Via
Benzinga
Key Takeaways From AbbVie Analyst Ratings
August 23, 2024
Via
Benzinga
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
September 05, 2024
There is something for everybody in America's $4.5 trillion healthcare market.
Via
The Motley Fool
AbbVie Stock Post Humira is Still an Attractive Stock to Hold
September 04, 2024
AbbVie's strategic diversification and strong financial position make it possible to sustain growth despite the perceived “Humira cliff.”
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
From
FN Media Group LLC
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
Via
Benzinga
2 Dividend Stocks You Can Safely Hold Through a Recession
September 02, 2024
These stocks can help you sleep peacefully at night, even in bad times.
Via
The Motley Fool
2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer
September 01, 2024
A drugmaker and a telecom business have what it takes to safely boost your passive income stream.
Via
The Motley Fool
Stock Market Rally Mixed; Dow Jones Hits High While Nvidia Tumbles On Earnings: Weekly Review
August 30, 2024
The Dow Jones hit a new high while Nvidia led a Nasdaq retreat.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
August 30, 2024
These businesses can stand the test of time in a diversified portfolio.
Via
The Motley Fool
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
August 30, 2024
These three have secure core businesses, plus multiple paths to grow.
Via
The Motley Fool
2 Incredibly Cheap Healthcare Stocks to Buy Now
August 30, 2024
Top healthcare stocks are a great addition to any portfolio.
Via
The Motley Fool
Biotech And Life Science Sector Update Summer Of 2024
August 29, 2024
It’s the slowest week of the year, we are at the market top and most earnings reports are good.
Via
Talk Markets
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
August 29, 2024
There are three operative words with these dividend stocks: buy and hold.
Via
The Motley Fool
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
August 28, 2024
Neurocrine Biosciences reports Phase 2 trial results for NBI-1117568 showing significant improvement in schizophrenia symptoms, with an 18.2-point reduction in PANSS scores at a 20 mg dose.
Via
Benzinga
Neurocrine Bio Dives As Schizophrenia Trial Results Lags Peers
August 28, 2024
As new schizophrenia drugs move toward approval, Neurocrine Biosciences reports a subpar outcome for its phase 2 trial.
Via
Investor's Business Daily
3 Best Growth Stocks to Own for the Next 10 Years
August 28, 2024
When in doubt, zoom out; these three growth stocks have a history of strong performance that is likely to continue for the next 10 years
Via
MarketBeat
Topics
Economy
Exposures
Economy
Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock
August 28, 2024
It'll be a while before there's any impact, but it could be a big deal.
Via
The Motley Fool
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
August 27, 2024
Drug companies are investing in schizophrenia treatments as patients are desperate for a drug that has few side effects, Bloomberg reports.
Via
Benzinga
Donald Trump Owns These 21 Dividend Kings. Should You?
August 26, 2024
Some of Trump's Dividend Kings deserve a crown more than others.
Via
The Motley Fool
Topics
Government
Exposures
Political
3 Unstoppable Dividend Stocks to Buy Right Now
August 25, 2024
These stocks are the A-team for income investors.
Via
The Motley Fool
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
August 23, 2024
Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite concerns, experts predict limited financial impact on companies like Pfizer,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
70
71
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.